Effects of antihypertensive therapy on platelet cytosolic calcium responses to low density lipoprotein cholesterol

Journal of Human Hypertension

Volumn 10, Issue 3, 1996, Pages 177-180

  Sowers, J R ^a,b,c   Raman, B B ^a   Afonso, L C ^a   Bedford Rice, K ^c   Standley, P R ^a,b,c  

^a Division of Reproductive Endocrinology and Infertility   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

LDL cholesterol; Platelet cytosolic calcium

Indexed keywords

CALCIUM ANTAGONIST; CALCIUM ION; ENALAPRIL; FELODIPINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VASOPRESSIN;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CALCIUM CELL LEVEL; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HUMAN CELL; HYPERTENSION; MALE; THROMBOCYTE;

AGED; AGED, 80 AND OVER; BLOOD PLATELETS; CALCIUM; CHOLESTEROL, LDL; CYTOSOL; DILTIAZEM; DRUG THERAPY, COMBINATION; ENALAPRIL; FELODIPINE; FEMALE; HUMANS; HYPERTENSION; MALE; METOPROLOL; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0029863771     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hansson L. How far should blood pressure be lowered? What is the role of the J-curve? Am J Hypertens 1990; 3: 726-729.
2. Sowers JR, Zemel MB, Standley PR. Calcium and hypertension. J Lab Clin Med 1989; 114 (4): 338-348.
3. Ram JL, Standley PR, Sowers JR. Calcium function in vascular smooth muscle and its relationship to hypertension. In: Epstein M and R Loutzenhiser (ed). Calcium Antagonists in Clinical Medicine. Hanley and Belfus Inc, St Louis, 1992, pp 29-48.
4. Byyny RL, Loverde M, Lloyd S. Cytosolic calcium and insulin resistance in elderly patients with essential hypertension. Am J Hypertens 1992; 5: 459-464.
5. Sowers JR, Epstein M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy: an update. Hypertension 1995; 26 (Part 1): 869-879.
6. Winocour PD, Halushla PV, Colwell JA. The platelets: physiology and pharmacology. In: Longenecker GL (ed). Academic Press, New York, 1985, pp 341-366.
7. Knorr M, Locher R, Vogt E. Rapid activation of human platelets by low concentrations of low-density lipoprotein via the phosphoinositol cycle. Eur J Biochem 1988; 172: 753-759.
8. Standley PR, Safdar A, Bapna C, Sowers JR. Increased platelet cytosolic calcium responses to low density lipoprotein in type II diabetes with and without hypertension. Am J Hypertens 1993; 6: 938-943.
9. Sachinidia A, Locker R, Mengden T, Vitter W. Low-density lipoprotein elevates intracellular calcium and pH in vascular smooth muscle cells and fibroblasts without mediation of LDL receptor. Biochem Biophys Res Comm 1990; 167: 353-358.
10. Hassal DG, Forrest LA, Bruckdorfer KP. Influence of plasma lipoproteins on platelet aggregation in a normal male population. Arteriosclerosis 1983; 3: 332-338.
11. Andrews HE, Aitken JW, Hassal DG. Intracellular mechanisms in the activation of human platelets by low-density lipoproteins. Biochem J 1987; 242: 559-564.
12. Aviram M. Modified forms of low density lipoprotein affect platelet aggregation in vitro. Thromb Res 1989; 53: 561-567.
13. Simpson LL et al. Antiproliferative effects of verapamil enantiomers on vascular smooth muscle cells. J Vasc Med Biol 1994; 5: 46-53.
14. Sowers JR. Antiatherosclerotic effects of calcium channel blockers. Postgraduate Medicine 1992; 92 (2): 265-268.
15. Standley PR, Zhang F, Ram JL, Sowers JR. Insulin attenuates vasopressin-induced calcium transients and a voltage-dependent calcium response in rat vascular smooth muscle cells. J Clin Invest 1991; 88: 1230-1236.
16. Standley PR, Gangasani S, Prakash R, Sowers JR. Human platelet calcium measurements: methodological considerations and comparisons with calcium mobilization in vascular smooth muscle cells. Am J Hypertens 1991; 4: 546-549.
17. Corvalho ACA, Colman RW, Lees RS. Platelet function in hyperlipoproteinemia. N Engl J Med 1974; 290: 434-438.
18. Joist JH, Baker RK, Schonfeld G. Increased in vivo and in vitro platelet function in type II and type IV hyperlipoproteinemia. Throm Res 1979; 15: 95-100.
19. Standley PR, Bakir MH, Sowers JR. Vascular insulin abnormalities, hypertension and accelerated atherosclerosis. Am J Kidney Dis 1993; 21 (6): 39-46.
20. Levy J, Gavin JR III, Sowers JR. Diabetes mellitus: a disease of abnormal cellular calcium metabolism? Am J Med 1994; 96: 260-273.
21. Walsh MF, Dominguez LJ, Sowers JR. Metabolic abnormalities in cardiac ischemia. Cardiology Clinics 1995; 13 (4): 529-538.